Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/15295
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chanpattana W. | |
dc.date.accessioned | 2021-04-05T04:33:26Z | - |
dc.date.available | 2021-04-05T04:33:26Z | - |
dc.date.issued | 2000 | |
dc.identifier.issn | 10950680 | |
dc.identifier.other | 2-s2.0-0034199344 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/15295 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034199344&doi=10.1097%2f00124509-200006000-00013&partnerID=40&md5=df3a98fda3febcb668df544b04f22ddb | |
dc.description.abstract | A treatment-resistant manic patient failed to respond to conventional treatment, adjunctive olanzapine (20 mg/day), clozapine (600 mg/day), or ECT alone, but did respond to ECT combined with low dose clozapine (200 mg/day). Maintenance ECT combined with clozapine resulted in a remission over the 18-month period. | |
dc.subject | clozapine | |
dc.subject | neuroleptic agent | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | bipolar disorder | |
dc.subject | case report | |
dc.subject | electroconvulsive therapy | |
dc.subject | human | |
dc.subject | long term care | |
dc.subject | male | |
dc.subject | multimodality cancer therapy | |
dc.subject | Adult | |
dc.subject | Antipsychotic Agents | |
dc.subject | Bipolar Disorder | |
dc.subject | Clozapine | |
dc.subject | Combined Modality Therapy | |
dc.subject | Electroconvulsive Therapy | |
dc.subject | Humans | |
dc.subject | Long-Term Care | |
dc.subject | Male | |
dc.title | Combined ECT and clozapine in treatment-resistant mania | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Journal of ECT. Vol 16, No.2 (2000), p.204-207 | |
dc.identifier.doi | 10.1097/00124509-200006000-00013 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.